Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Vitix is an antioxidant dietary supplement developed by ACM Laboratoire specifically designed to manage vitiligo and skin depigmentation. Its formulation features a patented melon extract rich in antioxidant enzymes, specifically Catalase and Superoxide Dismutase (SOD), combined with a complex of vitamins (C, E, B9, B12) and essential minerals (Selenium, Copper, Zinc). The supplement works by protecting skin cells against oxidative stress, which is a primary factor in the destruction of melanocytes and the resulting depigmentation seen in vitiligo. It is intended for oral administration and can be used as a monotherapy or as an adjunct to conventional treatments like UVB phototherapy to help restore pigment balance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Vitix.